Lead on Purpose

SEPTEMBER 8, 2009

Over 150 companies, including Durkee, Cremora, San Giorgio, Ronzoni, and McCormick, now use the entire line of Flapper products, and Weatherchem continues to lead the industry in offering the widest, most innovative array of closure products. Filed under: Integrity , Leadership , Purpose , Team Building , Trust Tagged: | Albert J.

Committee 140

Committee Automotive Ethics Productivity 140

Harvard Business Review

MARCH 28, 2012

The Swiss pharmaceutical giant Roche is nothing if not determined in its quest to acquire Illumina, the San Diego-based leader in genetic-sequencing equipment. An acquirer looking for innovation would have been likelier to try to buy Gateway, a company that is almost an after-thought now. billion tender offer directly to shareholders.

Innovation 12

Innovation Company Biotechnology CFO 12

Harvard Business Review

MAY 26, 2016

While a dynamic, competitive economy rewards innovative firms with high profits and punishes poor performers with low profits, sustained aggregate profits suggest, instead, that firms are able to get away with higher prices because competition is limited. If so, then high profits portend diminished productivity growth.

Pharmaceuticals 10

Pharmaceuticals Politics Price Chemicals 10

Harvard Business Review

JUNE 9, 2017

How the most innovative providers are creating value. Equally troublesome, almost all policies focus exclusively on payments and finances but ignore the powerful influence of careerism and other non-financial motives that may compromise objectivity far more than financial incentives. Insight Center. The Leading Edge of Health Care.

Conflict of Interest 9

Conflict of Interest Pharmaceuticals Policies Industry 9

Harvard Business Review

OCTOBER 26, 2017

“He that will not apply new remedies must expect new evils; for time is the greatest innovator,” stated Francis Bacon. As with many clusters, a university sits at its center: founded in AD 1088, the Studium of Bologna was the major educational innovation of Europe’s second millennium. How did the city make the leap?

Education 8

Education Pharmaceuticals Innovation Industry 8

Harvard Business Review

MAY 26, 2014

Four dynamics are driving this new era of health care innovation: Finally, there is a financial incentive to innovate. While we are only in the early days of the open data movement, innovative uses of data will empower new approaches to improving outcomes. Entrepreneurship Health Innovation'

Health Care 8

Health Care Venture Funding Entrepreneur Pharmaceuticals 8

Harvard Business Review

JUNE 20, 2017

For organizations seeking to become more adaptive and innovative, culture change is often the most challenging part of the transformation. Innovation demands new behaviors from leaders and employees that are often antithetical to corporate cultures, which are historically focused on operational excellence and efficiency.

Company 15

Company Agility Innovation Learning-by-Doing 15

Harvard Business Review

APRIL 2, 2018

To be sure, many factors influence health outcomes and the investments the health care system makes are only one input. But, like pharmaceuticals, each of these entities is represented by powerful lobbyists (such as physician and hospital organizations), who will strongly oppose any steps to reduce payments. For instance, the U.S.

Health Care 8

Health Care Insurance Pharmaceuticals Incentives 8

Harvard Business Review

OCTOBER 22, 2013

Innovation starts with new and novel ideas. When we surveyed over 300 global executives between 2008 and 2009, one of the primary concerns they expressed was their inability to compete long term without a solid innovation engine that can grow their top line. Finding ideas is never the problem — initially. Find Pivots.

Skills 8

Skills Power Six Sigma Disruptive Innovation 8

Harvard Business Review

AUGUST 14, 2018

ineffective innovation strategies. 5 Principles for Innovation in Emerging Markets. They operate in an environment where the barriers to entry are relatively low and the focus of competition is on product and business model innovations and service delivery, rather than the most advanced technologies. Related Video.

Competitive Advantage 11

Competitive Advantage Business Model Technology Marketing 11

Harvard Business Review

MAY 8, 2013

I recently conducted a study of 56 randomly selected companies involved in major change and innovation efforts in the high-tech, retail, pharmaceutical, banking, automotive, insurance, energy, non-profit, and health care industries. Nearly 68% of these large-scale change and innovative efforts failed.

Middle Management 8

Middle Management Management Automotive Pharmaceuticals 8

Harvard Business Review

JANUARY 12, 2017

To find out, the HBS Kraft Precision Medicine Accelerator , which we cochair, recently brought together leaders from some of the most innovative DTC companies: Under Armour, Rent the Runway, Wayfair, Peloton, and Uber, to name a few. What can the field of precision oncology learn from this DTC approach? Know the patient.

Company 8

Company Health Care Storytelling Pharmaceuticals 8

Harvard Business Review

OCTOBER 13, 2011

The pharmaceutical industry also creates products with complex interactions and potentially dangerous side effects. Banks can simulate the pharmaceutical approach, and learn much about consumer behavior and its evolution — without putting customers at risk. Here, the protocols from other industries can provide some insight.

Banking 10

Banking Pharmaceuticals Microfinance Risk Management 10

Harvard Business Review

MARCH 6, 2012

Technological innovation accounted for almost half of U.S. economic growth over the past 50 years, but the country's standing as the world's indisputable innovation leader is now at risk. At Merck, as part of our commitment to scientific innovation, we are working to foster the next generation of scientific leaders.

Education 11

Education Creativity How To Pharmaceuticals 11

Harvard Business Review

FEBRUARY 27, 2012

Michael Porter has done us all a service in identifying that the wealth of modern economies comes from the productivity, innovation and high wages found in their clustered industries — those industries that are found only in certain geographic areas and trade most of their output outside their home areas, both nationally and internationally.

Creativity 15

Creativity Porter Industry Pharmaceuticals 15

Harvard Business Review

JANUARY 24, 2012

I'll be joined by five CEOs, among them George Halvorson , who heads the health care provider Kaiser Permanente, Vincent Forlenza who runs Becton Dickinson, the pharmaceutical company, and Tim Brown , the CEO of IDEO, the design and innovation firm.

Meyer 14

Meyer Goleman Emotional Intelligence Pharmaceuticals 14

Harvard Business Review

MARCH 9, 2015

Rather than be paralyzed by fear about who has access to what, savvy leaders recognize that information can empower employees to move the business closer to customers, that decision-making can be accelerated when vital data is not held hostage (or lost) and that visible conversations can prevent wasted effort and even spark innovation.

Tools 8

Tools CEO Mezzanine Software 8

Harvard Business Review

MARCH 27, 2018

” It heightened concerns over today’s tech giants and the influence they have. That influence comes in part from data. Unlike some pharmaceuticals, data-opolies do not charge consumers exorbitant prices. Less innovation in markets dominated by data-opolies. political system, including the 2016 U.S.

Company 11

Company Advertising Incentives Engineering 11

Harvard Business Review

SEPTEMBER 26, 2011

This set has influenced them to place way too much emphasis on maximizing shareholder value and not enough on generating value for society. Some people may contend that given the high risks and many years it takes to develop a new drug, pharmaceutical companies are different animals from other firms. I disagree.

CEO 15

CEO Short-term Long-term Restructuring 15

Harvard Business Review

NOVEMBER 4, 2014

And pharmaceutical companies might not like how an objective tool judges their drugs. But we don’t require the decisions to be made transparently, systematically, and based on evidence — even though obscure economic incentives can influence, if not dictate, these institutional choices. Health Innovation'

Cost 8

Cost Committee Insurance Health Care 8

Harvard Business Review

NOVEMBER 4, 2014

And pharmaceutical companies might not like how an objective tool judges their drugs. But we don’t require the decisions to be made transparently, systematically, and based on evidence — even though obscure economic incentives can influence, if not dictate, these institutional choices. Health Innovation'

Cost 8

Cost Committee Insurance Health Care 8

Harvard Business Review

SEPTEMBER 7, 2015

Hiring policies influence morale, productivity and turnover, marketing efforts shape demand growth, and competitors fight back. How would a pharmaceutical company react, for example, when a new innovation disrupts the industry’s cost structure? Strategy games anticipate and amplify reality by acting like vaccinations.

Seminar 8

Seminar Learning Curve Strategy Comparison 8

Harvard Business Review

SEPTEMBER 3, 2013

Hilde Dach, the former chief scientist at drug-development start-up Genbac and now a team leader at German pharmaceuticals maker Caliska, which had acquired Genbac, could read disappointment in the face of Johan Greve, the Caliska division head who was her boss. You''ve always seen it as a pharmaceutical product. Hilde turned away.

Case Study 8

Case Study Pharmaceuticals Bottom-up Marketing 8

Harvard Business Review

NOVEMBER 28, 2017

Doing so entails operating more efficiently or innovating to create products that consumers value more. Touting profitability may impress investors who understand it as an indication of efficiency and innovation in the face of adversity. They may need reminders of their enormous collective power and influence.

Company 8

Company Short-term Long-term Price 8

Harvard Business Review

NOVEMBER 20, 2015

Corporate procurement processes are opaque, secretive, and can be influenced by political pull as well as pure performance. In the clubby world of pharmaceutical purchasing executives, PACIV’s reputation for transparency spread, setting a higher bar that his competitors begrudgingly were now asked to jump over.

Supply Chain 8

Supply Chain Collins Golden Handcuff Pharmaceuticals 8

Harvard Business Review

MAY 28, 2013

Not innovation, risk management, technology, debt, or the regulatory environment. Should some specific talent management practices receive greater focus than others--that is, do they exert more influence on competency of an organization''s overall talent management process? And what did they say was their biggest concern? Methodology.

Talent Management 8

Talent Management Company Telecommunications Management 8

Harvard Business Review

MAY 28, 2015

Instead, according to new research from the Center for Talent Innovation (CTI), the fundamental issue is the health care industry’s failure to develop a nuanced understanding of, and commitment to, women as consumers and decision makers. What is the greatest impediment preventing Americans from getting good health care?

Health Care 8

Health Care Industry First-mover Advantage Market Segmentation 8

Harvard Business Review

JUNE 24, 2015

The f ive forces framework for strategy may be valid in one arena, blue ocean or open innovation in another, but each approach to strategy tends to be presented or perceived as a panacea. The firm can innovate to address a tired industry business model or can recognize a megatrend before others see and act on it.

Strategy 8

Strategy Competitive Advantage Environment Execution 8

Harvard Business Review

OCTOBER 26, 2017

Identify whether your organization has the ability, based on market size and/or influence, to get other parties to participate in a consortium. IoT sensors combined with blockchain could also help the pharmaceutical industry tackle a major public safety issue—counterfeit drugs.

Supply Chain 8

Supply Chain Content Power Transportation 8

Harvard Business Review

SEPTEMBER 11, 2014

For example, restaurants and hotels often have difficulty predicting demand for their services, because many factors influence whether, when, and where people eat out or travel. Finally, industries in the upper-right quadrant — such as software, pharmaceuticals, and medical equipment — face high uncertainty in both demand and technology.

Uncertainty 22

Uncertainty Industry Bottom-up Technology 22

Harvard Business Review

NOVEMBER 3, 2017

When everyone in the organization feels empowered to make decisions that can influence change, it creates a palpable energy: People tend to work harder, offer more ideas, and become far more invested in the process. The company defined a new growth strategy that would require a significant improvement in its ability to innovate rapidly.

Execution 14

Execution Strategy Decentralization Short-term 14

Harvard Business Review

JULY 6, 2016

For 78-year-old Tony, 3,4 DAP — which can be obtained at low cost from compounding pharmacies or for free through a compassionate-use program supported by a small privately held company, Jacobus Pharmaceuticals — is a lifesaver. Pharmaceutical companies traditionally invest heavily in research and development.

Price 15

Price Pharmaceuticals Company Health Care 15

Harvard Business Review

JULY 18, 2017

It favors an ACA-like structure that subsidizes insurance for low-income individuals and families, and argues that a single-payer system would stymie private-sector innovation, create long waiting periods, and offer less patient choice. One is the American Medical Association. However, the AMA is far from a disinterested party.

Health Care 8

Health Care System Insurance Decentralization 8

Harvard Business Review

FEBRUARY 24, 2017

It’s also possible that members of Congress use their influence to benefit the firms in which they invest. Thus, companies that have congressional stockholders no longer need to spend as much money on lobbying to influence opinion. Not only did his wife invest between $610,000 and $1.5

Conflict of Interest 8

Conflict of Interest Committee Collins Politics 8

Harvard Business Review

OCTOBER 8, 2013

pharmaceuticals, physical therapy, skilled nursing facility care). REBP can also help acute-care providers reinforce and accelerate existing strategic priorities, such as improving how hospitals influence and partner with physicians, increase adoption of clinical pathways , and reduce input costs. Leading Health Care Innovation.

Health Care 8

Health Care Cost Analysis Competitive Advantage 8